Related Experiment Video
Updated: Nov 22, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Ketamine treatment for depression: qualitative study exploring patient views
Sagar Jilka1, Clarissa Mary Odoi1, Emma Wilson2
1Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK; and South London and Maudsley NHS Foundation Trust, UK.
Patients are enthusiastic about ketamine for depression but require more information on its safe use and societal impact before widespread adoption. Patient input is crucial for successful implementation and policy decisions regarding this promising treatment.
Area of Science:
- Psychiatry
- Pharmacology
- Public Health
Background:
- Ketamine shows promise for treating depression.
- Challenges include potential for abuse and implementation hurdles.
- Patient perspectives are vital for informed clinical use.
Purpose of the Study:
- To gather patient views on clinical ketamine use.
- To inform policy and practical decisions for large-scale ketamine rollout.
- To address patient concerns regarding safety, monitoring, and accessibility.
Main Methods:
- Qualitative study involving 14 patients with depression (no prior ketamine experience).
- Three focus groups and three validation sessions explored patient views.
- Thematic analysis was conducted by three service-user researchers.
Main Results:
- Five key themes emerged: public perception, risks, monitoring, privacy, and practicalities.
- Patients acknowledged ketamine's stigma and desired public education and long-term safety data.
- Concerns were raised about data misuse, with emphasis on monitoring for safe administration and evidence generation.
Conclusions:
- Patients are optimistic about ketamine but need more information for national rollout.
- Societal impact and patient involvement are essential for successful ketamine implementation.
- Further research and public engagement are necessary to address patient concerns and optimize ketamine therapy.
More Related Videos
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Electroconvulsive Therapy
The Placebo Effect
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview
Parenteral Anesthetics: Overview